HomeTagsHoth Therapeutics

Hoth Therapeutics

Biotechnology

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease

PR Newswire - July 13, 2022

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...

Biotechnology

Hoth Therapeutics Announces HREC Approval in Australia for the Next Phase of its Trial of BioLexa for Patients with Atopic Dermatitis

PR Newswire - June 22, 2022

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...

Biotechnology

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results – Reduce Amyloid β in Alzheimer’s Disease

PR Newswire - January 5, 2022

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ. The...

IoT in Manufacturing: Trends, Technologies, and Benefits

PsiQuantum to Build World’s First Utility-Scale, Fault-Tolerant Quantum Computer in Australia

Fresh Del Monte and University of Granada Announce Expanded Partnership to…

SES to Acquire Intelsat

Hoth Therapeutics

Hot Topics

IoT in Manufacturing: Trends, Technologies, and Benefits

PsiQuantum to Build World’s First Utility-Scale, Fault-Tolerant Quantum Computer in Australia

Fresh Del Monte and University of Granada Announce Expanded Partnership to Research the Effectiveness of Bioactive Compounds of Fruit Residues in Medical and Non-Medical...